Increased operating expenses largely contributed to the drop. Total revenue was up 13 percent over 2012, but operating expenses increased 17 percent, from $90.5 million in 2012 to $106.2 million this past quarter, which ended March 31.
More Articles on Devices:
35 Orthopedic & Spine Devices Receive FDA 510(k) Clearance
Medical Device Tax Costs Will Be Absorbed by Companies, Not Passed to Hospitals
Orthofix’s Slumped Spine, Orthopedic Sales Brought 17% Gross Profit Drop in Q1
